Poland· PL-100300302

Clostilbegyt

A clomifene product containing clomifeni citras, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC G03GB02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedClostilbegytATCG03GB02REGISTER NO.PL-100300302PACKS LISTED1CHECKEDJune 7, 2026

Where it is registered

Clomifene is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GB02 (clomifene), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Clomifene · ATC G03GB02

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of clomifene costs, country by country.

Normalised to the WHO defined daily dose (9 mg), the median price runs from $0.10 in Italy to $0.76 in United States — a ×7.3 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Clomifene · price per daily dose (9 mg)

USD · FX 28 Sept 2026

  • US United States$0.76 (acquisition cost)
  • FR France$0.14
  • IT Italy$0.10
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Clomifeni citras
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
G03GB02
ATC class
Clomifene
Defined daily dose
9 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
June 7, 2026

Packs & prices · 1

  • gtin
    05909997224534

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for clomifene.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Clomifene · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clomifene in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clomifene products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Clomiphen Viatris
  • Belgium · Clomid
  • Bulgaria · Клостилбегит
  • Cyprus · Duinum, Fertilan
  • Czechia · Clostilbegyt
  • Germany · Clomifen Ratiopharm
  • Spain · Omifin
  • France · Clomid
  • United Kingdom (Northern Ireland) · Clomid, Clomifene Wockhardt Uk
  • Greece · Clomiphene Citrate Anfarm
  • Hungary · Clostilbegyt
  • Ireland · Clomid
  • Italy · Clomid
  • Lithuania · Clostilbegyt
  • Luxembourg · Clomid
  • Latvia · Clostilbegyt
  • Netherlands · Clomifeencitraat Cf
  • Portugal · Dufine
  • Romania · Clostilbegyt
  • Slovakia · Clostilbegyt

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/96b5dcf2-ca2d-43d0-b89c-6b0f6e99cc1c
GET /v1/drugs/96b5dcf2-ca2d-43d0-b89c-6b0f6e99cc1c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909997224534 ¦ Rp ¦ 85065\n10 tabl.",
  "substance": null,
  "common_name": "Clomifeni citras",
  "pl_product_id": "100300302",
  "pozwolenie_nr": "268/13",
  "auth_procedure": "IR",
  "authorisation_validity": "2023-06-07"
}

See everything about clomifene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.